Sutro Biopharma (STRO) — Free Cash Flow Generation Index
Latest as of June 2024:
0.92x
Sutro Biopharma (STRO) has a Free Cash Flow Generation Index of 0.92x as of June 2024. Free cash flow of $8.70 Million represents 1% of operating cash flow ($9.46 Million). Read debt load of Sutro Biopharma for a breakdown of total debt and financial obligations.
FCF Generation Index
0.92x
Free Cash Flow / Operating CF
Free Cash Flow
$8.70 Million
USD
Operating Cash Flow
$9.46 Million
USD
Capital Expenditures
$756.00K
USD
Sutro Biopharma Free Cash Flow Generation Index (2018–2022)
Historical FCF Generation Index trend for Sutro Biopharma across 2 annual periods. Explore reinvestment intensity of Sutro Biopharma to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Sutro Biopharma (2018–2022)
Year-by-year Free Cash Flow Generation Index for Sutro Biopharma. For the full company profile including market capitalisation, see STRO company net worth.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | -1.21x | $-4.31 Million | $3.55 Million | $7.86 Million | ▼ -238.4% |
| 2018 | 0.88x | $11.13 Million | $12.68 Million | $1.56 Million | — |
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).